Nonviral gene transfer strategies to promote bone regeneration

Journal of Biomedical Materials Research - Part A

Volumn 101, Issue 10, 2013, Pages 3009-3018

  Im, Gun Il ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

Author keywords

bone regeneration; gene transfer; nonviral

Indexed keywords

BONE REGENERATION; CHEMICAL METHOD; CLINICAL SITUATIONS; CONVENTIONAL TREATMENTS; NONVIRAL; NONVIRAL GENE TRANSFER; SURGICAL TREATMENT; THERAPEUTIC GENES;

BONE; GENE THERAPY;

GENE TRANSFER;

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN SPONGE; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; GROWTH FACTOR; HYDROXYAPATITE; NAKED DNA; NANOPARTICLE; OSTEOGENIC PROTEIN 1; PLASMID DNA; POLYETHYLENEIMINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

BONE DEFECT; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REGENERATION; BONE REMODELING; CARTILAGE CELL; COST EFFECTIVENESS ANALYSIS; DENDRITIC CELL; DNA TRANSFECTION; ELECTROPORATION; EX VIVO STUDY; FRACTURE HEALING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO GENE TRANSFER; LIPID VESICLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; OPSONIZATION; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; RETICULOENDOTHELIAL SYSTEM; REVIEW; SYSTEMIC CIRCULATION; TISSUE ENGINEERING; TRANSIENT EXPRESSION;

BONE REGENERATION; GENE TRANSFER; NONVIRAL;

ANIMALS; BONE REGENERATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; RNA; VIRUSES; WOUND HEALING;

EID: 84883246894     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34576     Document Type: Review

References (127)

1. Einhorn TA,. The science of fracture healing. J Orthop Trauma 2005; 19: S4-S6.
2. Hollinger JO, Kleinschmidt JC,. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1990; 1: 60-68.
3. Evans CH,. Gene therapy for bone healing. Expert Rev Mol Med 2010; 12: e18.
4. Gruber R, Koch H, Doll BA, Tegtmeier F, Einhorn TA, Hollinger JO,. Fracture healing in the elderly patient. Exp Gerontol 2006; 41: 1080-1093.
5. Giannoudis P, Tzioupis C, Almalki T, Buckley R,. Fracture healing in osteoporotic fractures: Is it really different? A basic science perspective. Injury 2007; 38: S90-S99.
6. McKee MD,. Management of segmental bony defects: the role of osteoconductive orthobiologics. J Am Acad Orthop Surg 2006; 14: S163-S167.
7. Myeroff C, Archdeacon M,. Autogenous bone graft: donor sites and techniques. J Bone Joint Surg Am. 2011; 93: 2227-2236.
8. Kim DH, Rhim R, Li L, Martha J, Swaim BH, Banco RJ, Jenis LG, Tromanhauser SG,. Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J 2009; 9: 886-892.
9. Delloye C, Cornu O, Druez V, Barbier O,. Bone allografts: What they can offer and what they cannot. J Bone Joint Surg Br 2007; 89: 574-579.
10. Simpson AH, Mills L, Noble B,. The role of growth factors and related agents in accelerating fracture healing. J Bone Joint Surg Br 2006; 88: 701-705.
11. Kwong FN, Harris MB,. Recent developments in the biology of fracture repair. J Am Acad Orthop Surg 2008; 16: 619-625.
12. Lieberman JR, Ghivizzani SC, Evans CH,. Gene transfer approaches to the healing of bone and cartilage. Mol Ther 2002; 6: 141-147.
13. Anderson WF,. Human gene therapy. Nature 1998; 392: 25-30.
14. Kofron MD, Laurencin CT,. Bone tissue engineering by gene delivery. Adv Drug Deliv Rev 2006; 58: 555-576.
15. Gamradt SC, Lieberman JR,. Genetic modification of stem cells to enhance bone repair. Ann Biomed Eng 2004; 32: 136-147.
16. Heilbronn R, Weger S,. Viral vectors for gene transfer: Current status of gene therapeutics. Handb Exp Pharmacol 2010; 197: 143-170.
17. Evans C,. Gene therapy for the regeneration of bone. Injury 2011; 42: 599-604.
18. Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, Martinache C, Rieux-Laucat F, Latour S, Belohradsky BH, Leiva L, Sorensen R, Debre M, Casanova JL, Blanche S, Durandy A, Bushman FD, Fischer A, Cavazzana-Calvo M,. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2010; 363: 355-364.
19. Oakes DA, Lieberman JR,. Osteoinductive applications of regional gene therapy: Ex vivo gene transfer. Clin Orthop Relat Res 2000; 379 Suppl: S101-S112.
20. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL,. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468.
21. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM,. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93: 662-670.
22. Andree C, Swain WF, Page CP, Macklin MD, Slama J, Hatzis D, Eriksson E,. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci USA 1994; 91: 12188-12192.
23. Eriksson E, Yao F, Svensjo T, Winkler T, Slama J, Macklin MD, Andree C, McGregor M, Hinshaw V, Swain WF,. In vivo gene transfer to skin and wound by microseeding. J Surg Res 1998; 78: 85-91.
24. Bleiziffer O, Eriksson E, Yao F, Horch RE, Kneser U,. Gene transfer strategies in tissue engineering. J Cell Mol Med 2007; 11: 206-23.
25. Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P, Mathiesen I, Cortese R, Ciliberto G, Laufer R, La Monica N, Fattori E,. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 1999; 96: 6417-6422.
26. Haleem-Smith H, Derfoul A, Okafor C, Tuli R, Olsen D, Hall DJ, Tuan RS,. Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol 2005; 30: 9-20.
27. Lakshmipathy U, Pelacho B, Sudo K, Linehan JL, Coucouvanis E, Kaufman DS, Verfaillie CM,. Efficient transfection of embryonic and adult stem cells. Stem Cells 2004; 22: 531-543.
28. Ferreira E, Potier E, Logeart-Avramoglou D, Salomskaite-Davalgiene S, Mir LM, Petite H,. Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Ther 2008; 15: 537-544.
29. Mayer CR, Geis NA, Katus HA, Bekeredjian R,. Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin Drug Deliv 2008; 5: 1121-1138.
30. Guo X, Huang L,. Recent advances in nonviral vectors for gene delivery. Acc Chem Res 2010; 45: 971-979.
31. Chen Z, Liang K, Liu J, Xie M, Wang X, Lu Q, Zhang J, Fang L,. Enhancement of survivin gene downregulation and cell apoptosis by a novel combination: Liposome microbubbles and ultrasound exposure. Med Oncol 2009; 26: 491-500.
32. Negishi Y, Matsuo K, Endo-Takahashi Y, Suzuki K, Matsuki Y, Takagi N, Suzuki R, Maruyama K, Aramaki Y,. Delivery of an angiogenic gene into ischemic muscle by novel bubble liposomes followed by ultrasound exposure. Pharm Res 2011; 28: 712-719.
33. Hwang SJ, Davis ME,. Cationic polymers for gene delivery: Designs for overcoming barriers to systemic administration. Curr Opin Mol Ther 2001; 3: 183-191.
34. Dang JM, Leong KW,. Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev 2006; 58: 487-499.
35. Ratner BD, Bryant SJ,. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 2004; 6: 41-75.
36. Fang J, Zhu YY, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, McCauley LK, Davidson BL, Roessler BJ,. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996; 93: 5753-5758.
37. Winn SR, Chen JC, Gong X, Bartholomew SV, Shreenivas S, Ozaki W,. Non-viral-mediated gene therapy approaches for bone repair. Orthod Craniofac Res 2005; 8: 183-190.
38. Xu L, Anchordoquy T,. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci 2011; 100: 38-52.
39. Malam Y, Lim EJ, Seifalian AM,. Current trends in the application of nanoparticles in drug delivery. Curr Med Chem 2011; 18: 1067-1078.
40. Wang J, Lu Z, Wientjes MG, Au JL,. Delivery of siRNA therapeutics: Barriers and carriers. AAPS J 2010; 12: 492-503.
41. Saranya N, Moorthi A, Saravanan S, Devi MP, Selvamurugan N,. Chitosan and its derivatives for gene delivery. Int J Biol Macromol 2011; 48: 234-238.
42. Posadas I, Guerra FJ, Cena V,. Nonviral vectors for the delivery of small interfering RNAs to the CNS. Nanomedicine 2010; 5: 1219-1236.
43. Sokolova V, Epple M,. Inorganic nanoparticles as carriers of nucleic acids into cells. Angew Chem Int Ed Engl 2008; 47: 1382-1395.
44. Prijic S, Sersa G,. Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol 2011; 45: 1-16.
45. Chowdhury EH, Akaike T,. Bio-functional inorganic materials: an attractive branch of gene-based nano-medicine delivery for 21st century. Curr Gene Ther 2005; 5: 669-676.
46. Kawano T, Yamagata M, Takahashi H, Niidome Y, Yamada S, Katayama Y, Niidome T,. Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses. J Control Release 2006; 111: 382-389.
47. Kim TN, Feng QL, Kim JO, Wu J, Wang H, Chen GC, Cui FZ,. Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite. J Mater Sci Mater Med 1998; 9: 129-134.
48. Shen H, Tan J, Saltzman WM,. Surface-mediated gene transfer from nanocomposites of controlled texture. Nat Mater 2004; 3: 569-574.
49. Kumar MN, Mohapatra SS, Kong X, Jena PK, Bakowsky U, Lehr CM,. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. J Nanosci Nanotechnol 2004; 4: 990-994.
50. Perez RA, Ginebra MP, Spector M,. Cell response to collagen-calcium phosphate cement scaffolds investigated for nonviral gene delivery. J Mater Sci Mater Med 2011; 22: 887-897.
51. Tierney EG, Duffy GP, Hibbitts AJ, Cryan SA, O'Brien FJ,. The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds. J Control Release 2012; 158: 304-311.
52. Yamamoto A, Kormann M, Rosenecker J, Rudolph C,. Current prospects for mRNA gene delivery. Eur J Pharm Biopharm 2009; 71: 484-489.
53. Bonetta L,. RNA-based therapeutics: Ready for delivery? Cell 2009; 136: 581-584.
54. Takahashi Y, Nishikawa M, Takakura Y,. Nonviral vector-mediated RNA interference: Its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Adv Drug Deliv Rev 2009; 61: 760-766.
55. Qiu P, Ziegelhoffer P, Sun J, Yang NS,. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther 1996; 3: 262-268.
56. Whitehead KA, Langer R, Anderson DG,. Knocking down barriers: Advances in siRNA delivery. Nat Rev Drug Discov 2009; 8: 129-138.
57. Mei J, Gao Y, Zhang L, Cai X, Qian Z, Huang H, Huang W,. VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro. Exp Oncol 2008; 30: 29-34.
58. Schaffert D, Wagner E,. Gene therapy progress and prospects: Synthetic polymer-based systems. Gene Ther 2008; 15: 1131-1138.
59. Tavernier G, Andries O, Demeester J, Sanders NN, De Smedt SC, Rejman J,. mRNA as gene therapeutic: How to control protein expression. J Control Release 2011; 150: 238-247.
60. Li SD, Huang L,. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances. Curr Opin Investig Drugs 2008; 9: 1317-1323.
61. Tokatlian T, Segura T,. siRNA applications in nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010; 2: 305-315.
62. Schreier H,. The new frontier: Gene and oligonucleotide therapy. Pharm Acta Helv 1994; 68: 145-159.
63. Donze O, Picard D,. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res 2002; 30: e46.
64. Sazani P, Astriab-Fischer A, Kole R,. Effects of base modifications on antisense properties of 2′-O-methoxyethyl and PNA oligonucleotides. Antisense Nucleic Acid Drug Dev 2003; 13: 119-128.
65. Sokolova V, Kovtun A, Heumann R, Epple M,. Tracking the pathway of calcium phosphate/DNA nanoparticles during cell transfection by incorporation of red-fluorescing tetramethylrhodamine isothiocyanate-bovine serum albumin into these nanoparticles. J Biol Inorg Chem 2007; 12: 174-179.
66. Gary DJ, Puri N, Won YY,. Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release 2007; 121: 64-73.
67. Haupenthal J, Baehr C, Kiermayer S, Zeuzem S, Piper A,. Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum. Biochem Pharmacol 2006; 71: 702-710.
68. Cherng JY, Talsma H, Verrijk R, Crommelin DJ, Hennink WE,. The effect of formulation parameters on the size of poly-((2-dimethylamino)ethyl methacrylate)-plasmid complexes. Eur J Pharm Biopharm 1999; 47: 215-224.
69. Malone RW, Felgner PL, Verma IM,. Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA 1989; 86: 6077-6081.
70. Erbacher P, Roche AC, Monsigny M, Midoux P,. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes. Exp Cell Res 1996; 225: 186-194.
71. Goldberg M, Langer R, Jia X,. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007; 18: 241-268.
72. Caminade AM, Turrin CO, Majoral JP,. Dendrimers and DNA: combinations of two special topologies for nanomaterials and biology. Chemistry 2008; 14: 7422-7432.
73. Martino S, di Girolamo I, Tiribuzi R, D'Angelo F, Datti A, Orlacchio A,. Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells. J Biomed Biotechnol 2009; 2009: 410260.
74. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J,. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002; 110: 751-759.
75. Wegman F, Bijenhof A, Schuijff L, Oner FC, Dhert WJ, Alblas J,. Osteogenic differentiation as a result of BMP-2 plasmid DNA based gene therapy in vitro and in vivo. Eur Cell Mater 2011; 21: 230-242; discussion 42.
76. Lu K, Zeng D, Zhang Y, Xia L, Xu L, Kaplan DL, Jiang X, Zhang F,. BMP-2 gene modified canine bMSCs promote ectopic bone formation mediated by a nonviral PEI derivative. Ann Biomed Eng 2011; 39: 1829-1839.
77. Wegman F, Geuze RE, van der Helm YJ, Cumhur Oner F, Dhert WJ, Alblas J,. Gene delivery of bone morphogenetic protein-2 plasmid DNA promotes bone formation in a large animal model. J Tissue Eng Regen Med 2012, online published Aug 6 2012.
78. Matsubara H, Tsuchiya H, Watanabe K, Takeuchi A, Tomita K,. Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: A preliminary study. Clin Orthop Relat Res 2008; 466: 2962-2972.
79. Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S,. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 2008; 108: 18-31.
80. Koh JT, Zhao Z, Wang Z, Lewis IS, Krebsbach PH, Franceschi RT,. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. J Dent Res 2008; 87: 845-849.
81. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C,. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res 2004; 19: 2021-2032.
82. Rose LC, Kucharski C, Uludag H,. Protein expression following non-viral delivery of plasmid DNA coding for basic FGF and BMP-2 in a rat ectopic model. Biomaterials 2012; 33: 3363-3374.
83. Li BC, Zhang JJ, Xu C, Zhang LC, Kang JY, Zhao H,. Treatment of rabbit femoral defect by firearm with BMP-4 gene combined with TGF-beta1. J Trauma 2009; 66-62: 450-456.
84. Zhao Z, Wang Z, Ge C, Krebsbach P, Franceschi RT,. Healing cranial defects with AdRunx2-transduced marrow stromal cells. J Dent Res 2007; 86: 1207-1211.
85. Lee JS, Lee JM, Im GI,. Electroporation-mediated transfer of Runx2 and Osterix genes to enhance osteogenesis of adipose stem cells. Biomaterials 2011; 32: 760-768.
86. Itaka K, Ohba S, Miyata K, Kawaguchi H, Nakamura K, Takato T, Chung UI, Kataoka K,. Bone regeneration by regulated in vivo gene transfer using biocompatible polyplex nanomicelles. Mol Ther 2007; 15: 1655-1662.
87. Lee SJ, Kang SW, Do HJ, Han I, Shin DA, Kim JH, Lee SH,. Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells. Biomaterials 2010; 31: 5652-5659.
88. Boden SD, Liu Y, Hair GA, Helms JA, Hu D, Racine M, Nanes MS, Titus L,. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. Endocrinology 1998; 139: 5125-5134.
89. Sangadala S, Boden SD, Viggeswarapu M, Liu Y, Titus L,. LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads. J Biol Chem 2006; 281: 17212-17219.
90. Boden SD, Titus L, Hair G, Liu Y, Viggeswarapu M, Nanes MS, Baranowski C,. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine (Phila Pa 1976) 1998; 23: 2486-2492.
91. Lattanzi W, Parrilla C, Fetoni A, Logroscino G, Straface G, Pecorini G, Stigliano E, Tampieri A, Bedini R, Pecci R, Michetti F, Gambotto A, Robbins PD, Pola E,. Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models. Gene Ther 2008; 15: 1330-1343.
92. Parrilla C, Lattanzi W, Rita Fetoni A, Bussu F, Pola E, Paludetti G,. Ex vivo gene therapy using autologous dermal fibroblasts expressing hLMP3 for rat mandibular bone regeneration. Head Neck 2010; 32: 310-318.
93. Pola E, Gao W, Zhou Y, Pola R, Lattanzi W, Sfeir C, Gambotto A, Robbins PD,. Efficient bone formation by gene transfer of human LIM mineralization protein-3. Gene Ther 2004; 11: 683-693.
94. Wan DC, Pomerantz JH, Brunet LJ, Kim JB, Chou YF, Wu BM, Harland R, Blau HM, Longaker MT,. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem 2007; 282-286: 26450-26459.
95. Kwong FN, Richardson SM, Evans CH,. Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells. Arthritis Res Ther 2008; 10-3: R65.
96. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, Kabo JM, Finerman GA, Berk AJ, Witte ON,. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 1999; 81: 905-917.
97. Lieberman JR, Le LQ, Wu L, Finerman GA, Berk A, Witte ON, Stevenson S,. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 1998; 16: 330-339.
98. Virk MS, Conduah A, Park SH, Liu N, Sugiyama O, Cuomo A, Kang C, Lieberman JR,. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone 2008; 42: 921-931.
99. Peterson B, Iglesias R, Zhang J, Wang JC, Lieberman JR,. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting. Spine (Phila Pa 1976) 2005; 30: 283-289; discussion 9-90.
100. Miyazaki M, Sugiyama O, Tow B, Zou J, Morishita Y, Wei F, Napoli A, Sintuu C, Lieberman JR, Wang JC,. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Spinal Disord Tech 2008; 21: 372-379.
101. Miyazaki M, Sugiyama O, Zou J, Yoon SH, Wei F, Morishita Y, Sintuu C, Virk MS, Lieberman JR, Wang JC,. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Spine (Phila Pa 1976) 2008; 33: 1410-1417.
102. Peterson B, Zhang J, Iglesias R, Kabo M, Hedrick M, Benhaim P, Lieberman JR,. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005; 11: 120-129.
103. Breitbart AS, Grande DA, Mason JM, Barcia M, James T, Grant RT,. Gene-enhanced tissue engineering: Applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg 1999; 42: 488-495.
104. Lee JY, Musgrave D, Pelinkovic D, Fukushima K, Cummins J, Usas A, Robbins P, Fu FH, Huard J,. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001; 83: 1032-1039.
105. Ishihara A, Zekas LJ, Litsky AS, Weisbrode SE, Bertone AL,. Dermal fibroblast-mediated BMP2 therapy to accelerate bone healing in an equine osteotomy model. J Orthop Res 2010; 28: 403-411.
106. Shin JH, Kim KH, Kim SH, Koo KT, Kim TI, Seol YJ, Ku Y, Rhyu IC, Chung CP, Lee YM,. Ex vivo bone morphogenetic protein-2 gene delivery using gingival fibroblasts promotes bone regeneration in rats. J Clin Periodontol 2010; 37: 305-311.
107. Dai KR, Xu XL, Tang TT, Zhu ZA, Yu CF, Lou JR, Zhang XL,. Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcif Tissue Int 2005; 77: 55-61.
108. Tang TT, Lu B, Yue B, Xie XH, Xie YZ, Dai KR, Lu JX, Lou JR,. Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats. J Bone Joint Surg Br 2007; 89: 127-129.
109. Xu XL, Tang T, Dai K, Zhu Z, Guo XE, Yu C, Lou J,. Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats. Acta Orthop 2005; 76: 637-646.
110. Chang SC, Lin TM, Chung HY, Chen PK, Lin FH, Lou J, Jeng LB,. Large-scale bicortical skull bone regeneration using ex vivo replication-defective adenoviral-mediated bone morphogenetic protein-2 gene-transferred bone marrow stromal cells and composite biomaterials. Neurosurgery 2009; 65: 75-81; discussion -3.
111. Evans CH, Palmer GD, Pascher A, Porter R, Kwong FN, Gouze E, Gouze JN, Liu F, Steinert A, Betz O, Betz V, Vrahas M, Ghivizzani SC,. Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng 2007; 13: 1987-1993.
112. Evans CH, Liu FJ, Glatt V, Hoyland JA, Kirker-Head C, Walsh A, Betz O, Wells JW, Betz V, Porter RM, Saad FA, Gerstenfeld LC, Einhorn TA, Harris MB, Vrahas MS,. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur Cell Mater 2009; 18: 96-111.
113. Viggeswarapu M, Boden SD, Liu Y, Hair GA, Louis-Ugbo J, Murakami H, Kim HS, Mayr MT, Hutton WC, Titus L,. Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J Bone Joint Surg Am 2001; 83: 364-376.
114. Horwitz EM, Dominici M,. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 2008; 10: 771-774.
115. Pelled G, Ben-Arav A, Hock C, Reynolds DG, Yazici C, Zilberman Y, Gazit Z, Awad H, Gazit D, Schwarz EM,. Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. Tissue Eng Part B Rev 2010; 16: 13-20.
116. Sheyn D, Kimelman-Bleich N, Pelled G, Zilberman Y, Gazit D, Gazit Z,. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther 2008; 15: 257-266.
117. Osawa K, Okubo Y, Nakao K, Koyama N, Bessho K,. Osteoinduction by microbubble-enhanced transcutaneous sonoporation of human bone morphogenetic protein-2. J Gene Med 2009; 11: 633-641.
118. Kishimoto KN, Watanabe Y, Nakamura H, Kokubun S,. Ectopic bone formation by electroporatic transfer of bone morphogenetic protein-4 gene. Bone 2002; 31: 340-347.
119. Kawai M, Bessho K, Kaihara S, Sonobe J, Oda K, Iizuka T, Maruyama H,. Ectopic bone formation by human bone morphogenetic protein-2 gene transfer to skeletal muscle using transcutaneous electroporation. Hum Gene Ther 2003; 14: 1547-1556.
120. Kawai M, Bessho K, Maruyama H, Miyazaki J, Yamamoto T,. Human BMP-2 gene transfer using transcutaneous in vivo electroporation induced both intramembranous and endochondral ossification. Anat Rec A Discov Mol Cell Evol Biol 2005; 287: 1264-1271.
121. Kawai M, Bessho K, Maruyama H, Miyazaki J, Yamamoto T,. Simultaneous gene transfer of bone morphogenetic protein (BMP) -2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression. BMC Musculoskelet Disord 2006; 7: 62.
122. Kotajima S, Kishimoto KN, Watanuki M, Hatori M, Kokubun S,. Gene expression analysis of ectopic bone formation induced by electroporatic gene transfer of BMP4. Ups J Med Sci 2006; 111: 231-241.
123. Granot Y, Rubinsky B,. Methods of optimization of electrical impedance tomography for imaging tissue electroporation. Physiol Meas 2007; 28: 1135-1147.
124. Bonadio J, Smiley E, Patil P, Goldstein S,. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med 1999; 5: 753-759.
125. Huang YC, Simmons C, Kaigler D, Rice KG, Mooney DJ,. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther 2005; 12: 418-426.
126. Lutz R, Park J, Felszeghy E, Wiltfang J, Nkenke E, Schlegel KA,. Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects. Clin Oral Implants Res 2008; 19: 590-599.
127. Endo M, Kuroda S, Kondo H, Maruoka Y, Ohya K, Kasugai S,. Bone regeneration by modified gene-activated matrix: Effectiveness in segmental tibial defects in rats. Tissue Eng 2006; 12: 489-497.